Short Interest in Lexaria Bioscience Corp. (NASDAQ:LEXXW) Increases By 700.0%

Lexaria Bioscience Corp. (NASDAQ:LEXXW) was the recipient of a significant growth in short interest in July. As of July 15th, there was short interest totalling 800 shares, a growth of 700.0% from the June 30th total of 100 shares. Based on an average trading volume of 16,000 shares, the short-interest ratio is currently 0.1 days.

Lexaria Bioscience Stock Performance

Shares of Lexaria Bioscience stock traded down $0.06 on Thursday, hitting $1.02. 1,472 shares of the company traded hands, compared to its average volume of 15,988. The stock’s 50 day moving average price is $1.19 and its 200-day moving average price is $1.06. Lexaria Bioscience has a 52 week low of $0.05 and a 52 week high of $2.50.

Lexaria Bioscience Company Profile

Lexaria Bioscience Corp. operates as a biotechnology company. It develops and out-licenses its patented drug delivery technology, DehydraTECH, which combines lipophilic molecules or active pharmaceutical ingredients with specific long-chain fatty acids and carrier compounds that improve the way they enter the bloodstream, increasing their effectiveness and allowing for lower overall dosing while promoting healthier oral ingestion methods.